Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 29% ± 11% | |
basal cell | 14 studies | 29% ± 15% | |
B cell | 11 studies | 20% ± 3% | |
endothelial cell of lymphatic vessel | 10 studies | 24% ± 6% | |
glutamatergic neuron | 9 studies | 37% ± 20% | |
ciliated cell | 9 studies | 34% ± 9% | |
epithelial cell | 8 studies | 30% ± 13% | |
adipocyte | 8 studies | 28% ± 4% | |
naive B cell | 8 studies | 19% ± 4% | |
macrophage | 7 studies | 22% ± 5% | |
memory B cell | 6 studies | 17% ± 1% | |
interneuron | 6 studies | 33% ± 18% | |
neuron | 5 studies | 30% ± 7% | |
fibroblast | 4 studies | 20% ± 4% | |
GABAergic neuron | 4 studies | 45% ± 12% | |
goblet cell | 4 studies | 27% ± 9% | |
classical monocyte | 3 studies | 22% ± 4% | |
non-classical monocyte | 3 studies | 24% ± 6% | |
microglial cell | 3 studies | 21% ± 1% | |
endothelial cell of vascular tree | 3 studies | 17% ± 2% | |
amacrine cell | 3 studies | 41% ± 18% | |
muscle cell | 3 studies | 19% ± 4% | |
type I pneumocyte | 3 studies | 22% ± 3% | |
dendritic cell | 3 studies | 28% ± 10% | |
abnormal cell | 3 studies | 25% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 3% | |
astrocyte | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6137.21 | 1445 / 1445 | 100% | 42.78 | 183 / 183 |
uterus | 100% | 4194.08 | 170 / 170 | 100% | 69.30 | 459 / 459 |
brain | 100% | 11886.78 | 2638 / 2642 | 100% | 56.63 | 705 / 705 |
thymus | 100% | 5716.34 | 652 / 653 | 100% | 45.81 | 605 / 605 |
bladder | 100% | 8013.81 | 21 / 21 | 100% | 72.52 | 503 / 504 |
prostate | 100% | 7718.46 | 245 / 245 | 100% | 43.81 | 501 / 502 |
skin | 100% | 7862.25 | 1809 / 1809 | 100% | 35.49 | 471 / 472 |
kidney | 100% | 5665.94 | 89 / 89 | 100% | 32.21 | 899 / 901 |
ovary | 100% | 4574.98 | 180 / 180 | 100% | 31.69 | 429 / 430 |
intestine | 100% | 6144.02 | 966 / 966 | 100% | 42.20 | 525 / 527 |
adrenal gland | 100% | 5537.33 | 258 / 258 | 100% | 39.51 | 229 / 230 |
breast | 100% | 7064.40 | 459 / 459 | 100% | 39.02 | 1113 / 1118 |
liver | 100% | 5472.03 | 226 / 226 | 99% | 27.47 | 403 / 406 |
lung | 99% | 4487.48 | 574 / 578 | 100% | 42.76 | 1151 / 1155 |
stomach | 99% | 3465.04 | 355 / 359 | 100% | 37.44 | 286 / 286 |
pancreas | 65% | 1319.26 | 213 / 328 | 99% | 48.03 | 176 / 178 |
adipose | 100% | 7297.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 37.81 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.40 | 29 / 29 |
muscle | 100% | 24284.45 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5569.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 55.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 53.54 | 1 / 1 |
blood vessel | 99% | 3404.15 | 1324 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 4790.43 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 63% | 1728.54 | 581 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030262 | Biological process | apoptotic nuclear changes |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | BLCAP |
Protein name | BLCAP apoptosis inducing factor Bladder cancer-associated protein Bladder cancer-associated protein (Bladder cancer 10 kDa protein) (Bc10) |
Synonyms | BC10 |
Description | FUNCTION: May regulate cell proliferation and coordinate apoptosis and cell cycle progression via a novel mechanism independent of both p53/TP53 and NF-kappa-B. . FUNCTION: May regulate cell proliferation and coordinate apoptosis and cell cycle progression via a novel mechanism independent of both p53/TP53 and NF-kappa-B. . FUNCTION: May regulate cell proliferation and coordinate apoptosis and cell cycle progression via a novel mechanism independent of both p53/TP53 and NF-kappa-B. . |
Accessions | A2A2K9 ENST00000397134.1 ENST00000456058.1 ENST00000373537.7 P62952 ENST00000414080.1 A2A2K8 ENST00000397135.1 ENST00000432507.1 ENST00000397137.5 ENST00000397131.1 ENST00000445723.5 ENST00000414542.6 A0A1Y8ELN7 |